Optimising patient enrolment and efficacy of precision oncology clinical trials

Bookmark and Share
Published: 10 Jul 2019
Views: 863
Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer Center, Houston, USA

Prof Apostolia-Maria Tsimberidou speaks to ecancer at the WIN 2019 Symposium in Paris about how clinical trials can be optimised in precision oncology.

She explains that in order to increase optimisation it is essential to have comprehensive molecular profiling for all patients.

Prof Tsimberidou states that implementing this is a challenge due to small fraction of cancer patients who are enrolled in clinical trials.